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ABSTRACT: The self-assembly of amyloid-β (Aβ) generates cytotoxic
oligomers linked to the onset and progression of Alzheimer’s disease
(AD). As many fundamental molecular pathways that control Aβ
aggregation are yet to be unraveled, an important strategy to control
Aβ cytotoxicity is the development of bioactive synthetic nanotools
capable of interacting with the heterogeneous ensemble of Aβ species and
remodel them into noncytotoxic forms. Herein, the synthesis of
nanosized, functional gallic acid (Ga)-based dendrimers with a precise
number of Ga at their surface is described. It is shown that these Ga-
terminated dendrimers interact by H-bonding with monomeric/
oligomeric Aβ species at their Glu, Ala, and Asp residues, promoting
their remodeling into noncytotoxic aggregates in a process controlled by
the Ga units. The multivalent presentation of Ga on the dendrimer surface
enhances their ability to interact with Aβ, inhibiting the primary and secondary nucleation of Aβ fibrillization and disrupting the Aβ
preformed fibrils.
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1. INTRODUCTION
Pathological protein/peptide aggregation is on the basis of
several neurodegenerative processes, such as the ones leading
to Alzheimer’s disease (AD).1 In AD, amyloid-β (Aβ) peptides
of different lengths (between 38 and 43 amino acids) are at the
onset and progression of the disease. These amyloidogenic Aβ
species are highly prone to aggregate into a diverse set of
supramolecular assemblies that range from short oligomers to
long fibrils. Aβ peptides are produced by cleavage of the
amyloid precursor protein (APP) promoted by the γ-secretase
complex.2 The resulting peptides are reported to produce
thermodynamically unstable oligomers (Aβo) with a high
propensity to self-assemble into stable β-sheet structures that
present a fibril-like morphology (Aβf). While high-molecular-
weight fibrils have been shown to be relatively inactive, smaller
aggregates (i.e., Aβo) have emerged as potent cytotoxins with
the ability to trigger neuronal cell death, both in vitro and in
vivo.3,4 In fact, Aβo species can diffuse through the intracellular
and pericellular spaces and interact with fundamental cellular
motifs, triggering, for example, the hyperphosphorylation of
Tau and hampering its ability to maintain the microtubules of
neurons, which leads to their disassembly and neuronal cell
death.5 The growth of Aβf in the cellular milieu occurs at the
fibril surface, an autocatalytic process usually referred to as
secondary nucleation, which is mediated by Aβo species.
6 In
addition to the size, Aβo differs from Aβf in the intermolecular
arrangement of the β-strands (antiparallel for Aβo vs parallel β-
sheet usually for Aβf).
7 These supramolecular assemblies are
typically maintained through H-bonding between the back-
bones of nearby peptide monomers, as well as by π−π stacking
between aromatic amino acid residues, making them key
targets for the inhibition of the Aβ supramolecular assembly.8
Natural polyphenols (e.g., epigallocatechin gallate,9 resver-
atrol,10 or vescalagin11) have been reported to remodel the
supramolecular structure of amyloidogenic proteins/pepti-
des.12 They usually interfere with the H-bonding and
hydrophobic interactions (e.g., π−π stacking) between the
protein/peptide chains that are responsible for the stabilization
of β-sheets present in the Aβ supramolecular species. These
perturbations usually lead to the formation of disordered Aβ
assemblies of low toxicity.9 Importantly, this ability of
polyphenols to interfere with the Aβ supramolecular assembly
is reported to be mediated by gallic acid (Ga) and other
phenolic units in their structures.13 Based on this bioactive
potential, herein, we mimicked the structure of discrete
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polyphenols by designing nanosized dendrimers functionalized
with an increasing number of Ga units (Figure 1A−D).
2. MATERIALS AND METHODS
2.1. Materials. All chemicals were purchased from Sigma-Aldrich
or Acros Organics and were used without further purification. All
solvents were of HPLC grade, purchased from Scharlab and Fisher
Chemical and used without further purification. DMSO and Et3N
were dried under 4 Å molecular sieves. H2O of Milli-Q grade was
obtained from a Millipore water purification system. 2[G1]-NH2·HCl
and 3[G1]-NH2·HCl were prepared following previously reported
procedures by our group.14
2.2. Synthesis of Ga-Terminated Dendrimers. The den-
drimers used were synthesized divergently from gallic acid (Ga)
repeating units. These dendrimers are composed of a hydrophilic
triethylene glycol molecule carrying a Ga group at its terminals. The
detailed synthesis of each Ga-terminated dendrimer can be found in
the Supporting Information.
2.3. Dendrimer Characterization. We used column chromatog-
raphy, NMR spectroscopy, infrared spectroscopy, mass spectrometry
(MS), and gel permeation chromatography (GPC) to confirm
synthesis of the Ga-terminated dendrimers, as shown in Figures
S1−S24.
Therefore, in the column chromatography studies, an automated
column chromatography was performed on a MPLC Teledyne ISCO
CombiFlash RF 200 psi with RediSep Rf columns refilled with silica
40 mm (from VWR Chemicals) or neutral aluminum oxide 60-mesh
(from Alfa Aesar). Samples were adsorbed onto silica 40 mm or
neutral aluminum oxide 60-mesh into solid cartridges. The NMR
spectra were recorded on a Varian Mercury 300 MHz spectrometer.
Chemical shifts are reported in ppm (δ units) downfield from internal
tetramethylsilane (CDCl3), or the residual solvent peak (CD3OD or
DMSO-d6). Mestre Nova 9.0 software (Mestrelab Research) was used
for spectral processing. The FT-IR spectra were recorded on a
PerkinElmer Spectrum Two spectrophotometer equipped with a
UATR accessory or Bruker Vertex 70v using KBr pellets. The mass
spectra were recorder on a Bruker Microtof spectrometer coupled to a
HPLC Agilent 1100 using atmospheric-pressure chemical ionization
(APCI). Samples were injected via flow injection analysis (FIA) using
a MeOH/aqueous solution of formic acid 0.1% 1:1, flow 0.2 mL/min.
Finally, the GPC experiments were performed on an Agilent 1100
series separation module using a PSS SDV precolumn (5 μm, 8 × 50
mm2), a PSS SDV Linear S column (5 μm, 8 × 300 mm2), and a PSS
SDV Lux Linear M column (5 μm, 8 × 300 mm2) equipped with an
Agilent 1100 series refractive index and UV detectors. THF was used
as the eluent at 1 mL/min. The samples were filtered through a 0.45
μm PTFE filter before injection.
2.4. Molecular Dynamics Simulations. All simulations were
carried out during 80 ns. The systems were formed with Aβf fibril
(2NAO pdb file15) composed of two fibril layers of three peptides
each (1−42 residues, total of six peptide molecules) and a 1:1 ratio of
each of the dendrimer:
• 2NAO solvated and neutralized;
• 2NAO + 6 Ga solvated and neutralized;
• 2NAO + 6 2G0-GaOH solvated and neutralized;
• 2NAO + 6 2G1-GaOH solvated and neutralized;
• 2NAO + 6 3G1-GaOH solvated and neutralized.
2G0-GaOH, 2G1-GaOH, and 3G1-GaOH were parametrized and
their topologies were built by merging dendrons whose topology was
built using ATB.16 The final system was minimized and simulated
using GROMACS with the force field Gromos54a7.17
2.5. Peptide Preparation. Human amyloid-β peptide (1−42)
was obtained by custom synthesis from GeneCust Europe
(Luxembourg). Stock solutions of 0.45 mg were prepared by
dissolving 10 mg of amyloid-β peptide (1−42, Aβ) in 2.217 mL of
HFIP (Fluorochem Ltd., UK) according to the protocol described by
Stine et al.18 In brief, Aβ was dissolved in HFIP (5 mg/mL) during 30
min at room temperature. HFIP was allowed to evaporate in open
tubes overnight in the fume hood, and later during an additional 1 h
under vacuum. Aβ aliquots were then stored at −20 °C and
reconstituted immediately before use: (i) for the monomeric Aβ
(Aβo) studies, 20 μL of DMSO (sonicated for 10 min in an
ultrasound bath) was added and immediately afterward, ice-cold water
was added (followed by 15 s of vortex) to a final concentration of 100
μM; (ii) for the fibrillar Aβ (Aβf) experiments, 20 μL of DMSO
(sonicated for 10 min in an ultrasound bath) was added and
Figure 1. Chemical structure of the (A) Ga molecule and Ga-terminated dendrimers synthesized in the present work: (B) 2G0-GaOH, (C) 2G1-
GaOH, and (D) 3G1-GaOH.
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immediately afterward, 10 mM HCl was added at room temperature,
diluting to a final concentration of 100 μM of Aβ, followed by
vortexing for 15 s and then incubated for 24 h at 37 °C.
2.6. Thioflavin-T (ThT) Assay. Fibril formation for Aβo was
followed by the ThT assay (assemblyFigure 2A) during several
days. Aβ peptide stock solution was prepared as described above. ThT
fluorescence was monitored by mixing Aβo solution (final
concentration of 25 μM on phosphate buffer 5 mM, with 0.1%
sodium azide, pH 7.2) with ThT (final concentration of 40 μM) and
different concentrations of Ga, 2G0-GaOH, 2G1-GaOH, and 3G1-
GaOH, i.e., concentration ratios Aβ:dendrimers of 1:0.5; 1:1, and 1:2.
ThT fluorescence was then recorded in a fluorescence spectrometer
(Jasco, FP-8500, Japan) during 6 and 8 days using an excitation
wavelength of 435 nm and an emission wavelength of 465 nm. Each
experiment was repeated in triplicate. The experiments for the
disassembly of Aβ fibrils, i.e., Aβf, were performed for 5 days using the
same experimental protocol.
2.7. Circular Dichroism (CD). CD was performed using a 1 mm
path length cell at 37 °C in a CD spectrometer (Jasco, J1500, Japan).
Spectra were recorded in the range between 200 and 260 nm with a
scan rate of 10 nm/min and a response time of 1 s. Three scans were
accumulated for each spectrum. For all of the CD experiments, the
Aβo/Aβf concentration was 25 μM with or without each dendrimer
for the different ratios: 1:0.5; 1:1, and 1:2.
2.8. Atomic Force Microscopy (AFM). For the acquisition of
AFM images, freshly cleaved mica was functionalized with a drop of
(3-aminopropyl)triethoxysilane (APTES, 200 μL) during 30 min at
room temperature. Afterward, the micas were rinsed with deionized
water and dried under a nitrogen flux. Each sample, Aβf peptide (30
μM) in the presence and absence of dendrimers, was spotted onto the
functionalized mica during 30 min, washed with water and dried
under nitrogen.
AFM images were acquired using a JPK Nanowizard 3 (JPK,
Germany) in air at room temperature under the AC mode. The scans
were acquired at a 512 × 512 pixel resolution using ACTA-SS probes
(k ∼ 37 N/m, AppNano), a drive frequency of ∼254 kHz, a setpoint
of ∼0.5 V, and a scanning speed of 1.0 Hz.
2.9. Scanning Transmission Electron Microscopy (STEM).
For the acquisitions of the STEM images, Aβf peptide (30 μM) in the
presence and absence of dendrimers, was spotted onto the TEM grids,
Carbon Type-B 400M Cu (IESMAT, Spain), during 3 min, followed
by the classic staining with UranyLess (10 μL each sample, for 2 min)
(EMS, UK). All samples were washed with water and dried under
nitrogen. STEM images were obtained using a high-resolution field
emission scanning electron microscope (SEMAuriga Compact,
Zeiss, Germany). The scans were acquired at a resolution of 2048 ×
1536 pixels, EHT = 3000 kV, WD = 2.9 mm, and magnification =
5000 K.
Figure 2. Optimized geometry from MD simulations of (A) Ga, (B) 2G0-GaOH, (C) 2G1-GaOH, and (D) 3G1-GaOH interacting with the full-
length Aβf at its ASP (red), ALA (blue), and GLU (light pink) residues.
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2.10. Western Blot (WB) Analysis. To assess the effect of
dendrimers in the size of the Aβ species, produced in the presence of
different Aβ:dendrimer ratios, i.e., 1:0.5; 1:1, and 1:2 (during 1 day
and 5 days), we ran a 12% Bis−Tris Gel Invitrogen NuPAGE, with
MES SDS Running Buffer gel (gel loading buffer without DTT),
followed by its transference to nitrocellulose membranes using the
iBlot 2 System. Next, the nitrocellulose membranes were blocked with
4% BSA for 1.5 h in TBS-T (TBS with 0.1% Tween 20%). After the
blocking, the membranes were incubated (overnight at 4 °C) with the
6E10 antibody (Aβ 1−161:1000 dilution in 4% BSA in TBS-T).
After washing three times in TBS-T, the membranes were incubated
(during 1.5 h at RT) in IRDye 800CW goat anti-mouse IgG
secondary antibody (1:10000 dilution in TBS-T). Finally, the WB
lanes were detected using an Odyssey Fc Imaging System (LI-COR
Inc., NE). The comparisons between bands in different lanes were
quantified using Fiji software.
2.11. Cell Studies. Neuroblastoma SH-SY5Y cells were cultured
at 37 °C in a humidified 95/5% air/CO2 atmosphere using
Dulbecco’s modified Eagles medium F-12 (Gibco, UK) supplemented
with 10% FBS (Gibco, UK) and 1% ATB (Gibco, UK) solution. The
cell medium was replaced every 2 days and cells were subcultured
once they reached 90% confluence. Cells were plated at a density of
25 000 cells per well on 96-well plates containing DMEM/F-12 media
(for AlamarBlue assay) and plated at a density of 50 000 cells per well
on 24-well plates containing DMEM/F-12 media (for the live/dead
assay). A typical experiment included the culture of the neuro-
blastoma cell line (SH-SY5Y) during 24 h or 5 days in the absence or
presence of dendrimers at different concentrations. Afterward, Aβo/
Aβf was added to the culture medium and, after an additional 24 h,
the cells were evaluated for their metabolic activity. The dendrimers
and Aβo/Aβf peptide were reconstituted in DMSO (0.02%), diluted
into DMEM/F-12 media, sterilized by UV, and immediately added to
the cells.
2.12. AlamarBlue Assay. Aβo/Aβf cytotoxicity was evaluated by
measuring the cell metabolic activity 24 h after the addition of Aβo/
Aβf at a concentration of 25 μM using AlamarBlue (indicator dye
BUF012B, Bio-Rad) according to the manufacturer’s instructions.
The fluorescence intensity of each experimental condition was
measured using an excitation wavelength of 530 nm and an emission
wavelength of 590 nm with a Synergy HT microplate reader (BioTek
Instruments). p-values were calculated using a two-tailed t-test. The
results are presented as mean ± SEM of six independent experiments
for each experimental condition.
2.13. Live/Dead Assay. Cell viability was also evaluated by the
live/dead assay using calcein AM (Life Technologies) to stain live
cells and propidium iodide (PI, Biotium, Inc.) to stain dead cells.
Viable cells were stained in green and dead cells were stained in red.
Briefly, cells were incubated for 20 min with both dyes and then
observed under a fluorescence microscope (Axio Imager Z1m, Zeiss,
Germany).
2.14. Quantification of the β-Sheet Content under Cell
Culture Determined by the ThT Assay. Cells were cultured with
Aβo/Aβf and dendrimers during 24 h. Afterward, 1% thioflavin-T
(ThT, in sterile D-PBS) was added to the wells. After 20 min, the
ThT fluorescence intensity was measured using a fluorescence
spectrometer (Jasco, FP-8500, Japan), using an excitation wavelength
of 435 nm and an emission wavelength of 465 nm with a bandwidth
of 10 nm. Each condition was repeated in triplicate and using data
from two independent experiments.19
2.15. Protein Expression. For immunostaining, fluorescence
images were collected after 1 and 5 days of cell culture. Samples were
washed twice with PBS, fixed in 10% neutral buffered formalin for 30
min at 4 °C, permeabilized with 0.1% Triton X-100 in PBS for 5 min,
and blocked with 3% BSA in PBS for 30 min at room temperature. To
evaluate the accumulation of Aβo, a primary antibody (oligomer
polyclonal antibody, clone A11, rabbit, 1:200 dilution in 1% w/v
BSA/PBS, Life Technologies) against Aβ oligomeric forms or a
primary antibody against Aβf aggregates (biotin anti-β-amyloid, 1−16
antibody, mouse IgG1, 1:200 dilution in 1% w/v BSA/PBS,
Biolegend) was employed, followed by the secondary antibody rabbit
anti-mouse Alexafluor-488 (1:500 dilution in 1% w/v BSA/PBS, anti-
mouse, Invitrogen). A phalloidin-TRITC conjugate was used (1:200
dilution in PBS for 30 min, Sigma) to assess the cytoskeleton
organization. Nuclei were counterstained with 1 mg/mL of 4,6-
diamidino-2-phenylindole (DAPI, Sigma) for 30 min. Samples were
washed with PBS and placed in an imaging dish for confocal
microscopy (Leica, TCS SP8).
2.16. Bio-AFM Experiments. The cell nanomechanical analysis
was performed using a JPK Nanowizard 3 (JPK, Germany) under PBS
at 37 °C. Force curves were acquired using sQube cantilever (with
tips of borosilicate spheres of 5 μm diameter, CP-qp-CONT-BSG,
sQube), presenting k ∼ 0.1 N/m. All cantilevers were calibrated
before performing the analysis using the JPK noncontact method. For
each experimental condition, at least 15 fixed cells were analyzed and
it was acquired at least 10 curves per cell. All force curves were fitted
using the Hertz model to obtain Young’s modulus.
For the cell height analysis, at least 10 cells per experimental
condition were analyzed under the JPK QI Imaging Mode, using
cantilevers qp-BioAC-CB1 (NanoSensors, Germany). To obtain cell
height data, cellular cross sections were retrieved from the AFM
height images. All of the presented data are averages of 10 cells with
the corresponding standard deviations.
3. RESULTS AND DISCUSSION
3.1. Synthesis of Ga-Terminated Dendrimers. For the
preparation of dendrimers functionalized with Ga units on the
periphery, we selected dendritic scaffolds of the gallic acid−
triethylene glycol (GATG) family14,20 with terminal amine
groups. GATG dendrimers are composed of Ga cores,
responsible of the multivalency, and long triethylene glycol
spacer arms intended to give flexibility to the macromolecular
structure. Depending on the nature of the dendritic core,
divalent or trivalent, GATG dendrimers are referred to as 2Gn
or 3Gn (n is the dendrimer generation). Amide coupling of the
2G0 and 2G1 aminodendrimers (EDC, HOBt) with a Ga
derivative with hydroxyl groups protected as benzyl ethers,
followed by deprotection (H2, Pd/C), afforded 2G0-GaOH (2
Ga units) and 2G1-GaOH (6 Ga units). We tested the
synthesis of the 2G2-GaOH dendrimer (18 Ga units, not
shown); however, its high hydrophobic character made it
insoluble in water. To generate a dendrimer of higher Ga
valency, the same strategy was applied to a 3G1 dendrimer,
leading to 3G1-GaOH (9 Ga units). All of the functional Ga-
based dendrimers were obtained in very good yields. Their
chemical characterization is described with convincing
evidence of a successful synthesis by 1H, 13C NMR, and IR
spectroscopy. Furthermore, their purity and monodispersity
were confirmed by gel permeation chromatography (Figures
S1−S24).
3.2. Molecular Dynamics Simulations of Dendrimer−
Aβ Interactions. The ability of 2G0-GaOH, 2G1-GaOH, and
3G1-GaOH was assessed to modulate the supramolecular
assembly of Aβ and to promote the formation of noncytotoxic
aggregates. We started by modeling the potential of the
dendrimers to disassemble the full-length Aβf by coarse-grain
all-atom molecular dynamics (MD) simulations (i.e., 2NAO
PDB structure,15 Figure S25). For this analysis, Aβo was not
considered since their dynamic character largely limits the
reproducibility of the data obtained during the relative short
timeframes of the simulations.21 We then assessed the stability
of Aβf in the presence and absence of dendrimers (Figures 2
and S26−S29 and Table S1).
All dendrimers exhibited strong and stable H-bonds with the
Glu, Ala, and Asp residues of the Aβf structure. The placement
of dendrimers in close proximity to the region 3−8 (i.e., Glu−
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Phe−Arg−His−Asp−Ser) increases the spacing between Aβ
strands (Figure 2 Asp (red), Ala (orange), and Glu (light
pink)), compromising the formation of stable β-sheets and
other secondary conformations maintained by the H-bonding
network.22 While Ga and the dendrimer with lower number of
Ga units (i.e., 2G0-GaOH) did not alter significantly, the
solvent-accessible surface area (SASA, Table S1) of Aβf, the
dendrimers presenting six Ga units (i.e., 2G1-GaOH)
significantly increased the Aβ SASA value. Further increment
in the number of Ga units, i.e., 3G1-GaOH (nine units),
reduced the SASA probably due to its high hydrophobic
character, that induces a higher interaction between the
dendrimers themselves at the expense of Aβ−dendrimer
interactions.
The number of H-bonds between Aβ and different
dendrimers proportionally increase with the number of Ga
units in the dendritic structure. Despite the constraints derived
from the increased hydrophobic character with multivalency,
our results clearly show that the Ga units are the chemical
moieties that mediate the interaction between the dendrimers
and Aβ. Importantly, in general, MD simulations indicate that
the dendrimers are able to interact with Aβf, 2G1-GaOH being
the most effective modulator of its supramolecular structure
under physiological conditions.
3.3. Interference of Dendrimers in the Aβ Supra-
molecular Assembly. The ability of the dendrimers to
interfere with the assembly of Aβ in vitro was then assessed
using the thioflavin-T (ThT) fluorescence assay. Fluorescence
spectra of the dendrimers revealed no major interference with
the ThT emission spectrum (Figures S30−S33). We analyzed
the dendrimers under both assembly (Aβo) and disassembly
(Aβf) conditions (Figure 3) to screen their potential to block
the Aβ supramolecular assembly, as well as to disrupt the
preassembled Aβ structures. The supramolecular assembly of
Aβo over time presents the typical sigmoidal curve (character-
istic of secondary nucleation and fibril elongation),23 which is
abolished in the presence of all dendrimers at any of the tested
concentrations. After the exponential growth phase of Aβo (at
day 3−4), the fluorescence reaches a plateau (at day 7). When
the inhibition of assembly is analyzed on a per Ga unit (Aβ:Ga
unit, 1:1 Figure S34A), we observe the same tendency for the
2G1-GaOH, presenting a lower ThT fluorescence, which is in
agreement with the results presented in Figure 3. While our
results are compatible with this conclusion, it is important to
note that ThT binding assays are not always reliable. ThT does
not recognize all types of Aβ supramolecular assemblies, which
make it necessary that the analysis of the interaction is
performed using other techniques, such as CD and/or WB.
Nonetheless, our initial results are consistent with a direct
relationship between multivalency and activity. Indeed, the
rational design of highly selective multivalent nanosystems has
several advantages,24 including a reduction of the concen-
tration needed to exert a specific bioactivity. Also, multivalency
drives the targeted activity to the area of interest by increasing
the local concentration of bioactive moieties (Ga units in our
case). The impact of the dendrimers in the disassembly
pathway (Aβf, Figures 3B and S34B) is also dependent on the
number of Ga units per dendrimer and their concentration, a
result consistent with the disruption of the interstrand H-
bonding of the β-sheets. These interactions lead to a new
thermodynamic equilibrium, i.e., formation of noncytotoxic
aggregates that are not recognized by ThT. As previously
referred, it is known that ThT does not bind to β-sheet rich
globular proteins due to their highly twisted β-sheets with a
lower content of β-strands.25
We then used circular dichroism (CD) spectroscopy to
evaluate the type of β-sheets present in the Aβ supramolecular
species generated upon interaction with the dendrimers. CD
showed that all dendrimers perturbed the Aβ secondary
structure (Figures S35−S42), probably leading to the
formation of noncytotoxic oligomers. CD spectra were fitted
using the BeStSel method26 for secondary structure estimation
Figure 3. (A) Inhibition of the Aβo aggregation kinetics and (B) disassembling of Aβf fibrils evaluated using the ThT assay. Ga, 2G0-GaOH, 2G1-
GaOH, and 3G1-GaOH, inhibited the Aβ fibril elongation and promote the rupture of Aβf fibrils at different molar ratios: 1:0.5, 1:1, and 1:2.
Dendrimers were mixed with Aβo in the lag-phase of the Aβ fibril formation or with Aβf in the plateau phase, and fluorescence was measured over 8
days (Aβo) or 5 days (Aβf). All experiments were performed at room temperature.
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(Figure 4). After 1 day of incubation, a decrease in the
antiparallel β-sheets for all Aβo:dendrimer ratios was already
visible, which were further reduced over 5 days of incubation.
Remarkably, in the disassembly Aβf:dendrimer experiments,
2G1-GaOH was able to abolish the antiparallel β-sheet content
to undetectable levels after 5 days of incubation. When the
activity was analyzed on a per Ga unit (Figure S43), 2G1-
GaOH and 3G1-GaOH, presenting higher number of Ga units
per dendrimer, revealed to be more efficient than Ga itself in
reducing the antiparallel conformations associated with the
Aβo cytotoxic forms, clearly showing that the multivalent
presentation of Ga units enhances the ability of the dendrimers
to interact with Aβo. These results are in accordance with the
ThT data, indicating a clear relationship between the
concentration and multivalency of the dendrimers and their
ability to interfere with the assembly of Aβ. These findings
support the superior capacity of 2G1-GaOH to inhibit the
catalytic mechanism that combines the growth of insoluble
amyloid fibrils and the generation of soluble oligomeric
aggregates and consequently secondary nucleation.
Next, we evaluated the morphological changes of the Aβf
aggregates upon contact with the dendrimers by AFM (Figure
5) and STEM (Figure S44). As expected, a reduction in the
number of small aggregates is observed, a morphological
presentation compatible with cytotoxic oligomers or other
small Aβ species. In addition, elongated fibrils are replaced by
unstructured aggregates (condensed and less organized) and/
or shorter fibers as a result of the interaction between Aβf and
the dendrimers. When the interaction was studied on a per Ga
unit basis by AFM, the dendrimers with higher number of Ga
units revealed to be more effective than monovalent Ga to
disrupt the Aβf assemblies (Figure S45). Overall, the
dendrimers were able to remodel the Aβ aggregation state
into species with a morphology compatible with a reduced
cytotoxicity. This remodeling is in agreement with CD and
ThT data and clearly supports the importance of a Ga
multivalent presentation to increase the ability of the
dendrimers to modulate the Aβ supramolecular assembly.
Western blot (WB, using the 6E10 antibody) allowed the
quantification of the aggregates of different sizes, i.e.,
monomers, oligomers, and fibrils, produced during the
assembly (Aβo) and disassembly (Aβf) processes (Figure 6).
In both cases, 2G1-GaOH shows the highest reduction in the
oligomeric and monomeric species after 1 and 5 days of
incubation (Figures S46 and S47). The antibody 6E10 is
specific for the 1−16 amino acids of the Aβ sequence,
requiring an intact N-terminal epitope that encloses the amino
acid sequence 3−8: Glu−Phe−Arg−His−Asp−Ser. From the
MD simulations, we found that dendrimers exhibit strong and
stable H-bonding interactions with Glu residues, so these
results are compatible with the ability of 2G1-GaOH to
interact directly with the Aβ N-terminal, blocking the epitope
recognized by the 6E10 antibody.
3.4. Ability of Dendrimers to Modulate Aβ Cytotox-
icity. After showing that the dendrimers (and particularly
2G1-GaOH) are able to modulate the supramolecular
assembly of Aβ, both under assembly and disassembly
conditions, we selected a neuroblastoma cell line (SH-SY5Y)
to evaluate the impact of this activity under cell culture
conditions.
Figure 4. Loss of antiparallel β-sheets for the (A) aggregation pathway (Aβo) and (B) disaggregation of (Aβf) following CD during 1 and 5 days.
All experiments were conducted using a Aβ:dendrimers ratio of 1:1, [Aβ] = 25 μM, and under constant agitation at 37 °C. Error bars = SD; n = 3.
CD data were fitted using BeStSelRMSD: 1.0283; NRMSD: 0.04966.
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All of the dendrimers were cytocompatible and able to
rescue cells from the cytotoxicity of Aβf and Aβo (measured by
AlamarBlue and live/dead assays observed under confocal
microscopy, at 1 and 5 days of cell culture conditions, Figures
S48−S57). Not surprisingly, when ThT was used to quantify
the β-sheets present under cell culture conditions for both the
assembly (Aβo) and disassembly (Aβf) experiments, ThT
fluorescence reduced by ∼50−60% in the presence of the
dendrimers (Figures S52−S54). Next, we used the 6E10
(stains Aβf, Figures 7, S55, and S56) and A11 (stains Aβo,
Figures S57 and S58) antibodies to assess the presence of Aβ
species in the pericellular space. We noticed that Aβ tends to
Figure 5. Representative AFM images of Aβf. Each dendrimer was added into an Aβf solution (at Aβ:dendrimer concentration molar ratios of 1:0.5,
1:1, and 1:2) and left to incubate for 24 h under constant agitation. Both compounds directly altered Aβf presentation. Fibers marked with blue
arrows and oligomers marked with green arrows in the Aβf control sample. Scale bars = 500 nm.
Figure 6. Relative densitometric bar graphs of (A) Aβo and (B) Aβf quantified by WB (using the antibody 6E10). Experiments performed using 25
μM of Aβ, 1:1 molar ratio of Aβ and dendrimers, at 37 °C in PBS, for 1 and 5 days. (C) Aβ peptide assembly and disassembly pathways.4
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aggregate (Aβf stained by 6E10) over the cell membrane, while
the smaller species (Aβo stained by A11) are internalized by
the cells. For both pathways, the 2G1-GaOH dendrimer
reduced the amount of Aβ supramolecular assemblies in the
cellular environment (Figure 7A,C).
Recent reports27 have shown that Aβ species interact with
the phospholipid bilayer changing the lipid environment. It has
been proposed that the transformation of the Aβ secondary
structure results in hydrophobic segments being exposed,
which increases their tendency to attach onto the membrane.
This interaction with the cell membrane disturbs the
cytoskeletal organization (i.e., assembly of actin filaments and
microtubules) influencing the cell mechanical properties,
which results in changes in cellular morphology and mechanics
(e.g., cell height and Young’s modulus).28 Therefore, we used
Bio-AFM to measure the nanomechanical properties of the
cells in the presence and absence of Aβ and dendrimers
(Figures 8, S59, and S60). Our results indicate that the
presence of Aβf increases the stiffness of the cell body, while
Aβo (being more toxic) decreases Young’s modulus and cell
height probably via Tau hyperphosphorylation leading to the
disassembly of microtubules. In all of the cases, the presence of
Figure 7. Immunofluorescence analysis of (A) Aβo (assembly) and (C) Aβf (disassembly) species in the SH-SY5Y cell culture (mAb 6E10) after
incubation with 2G1-GaOH for 1 and 5 days (Aβ: green, cell nuclei: blue). Scale bar = 200 μm (insets = 50 μm). (B) Aβ peptide aggregation
pathway.
Figure 8. Representative Bio-AFM topographic images of SH-SY5Y cells ((A) assembly and (B) disassembly) cultured in the presence of Aβ and a
1:1 molar ratio of 2G1-GaOH. ((C) assembly and (D) disassembly) Young’s modulus of SH-SY5Y cells as a function of the presence of Aβ and
dendrimers (molar ratio 1:1). Experiments were recorded after 24 h of incubation; Aβ concentration was set at 25 μM. Error bars = SD, ***p <
0.001, and **p < 0.01 (all vs control of no Aβ); ###p < 0.001 and ##p < 0.01 (all vs control of Aβ).
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dendrimers ameliorated the perturbations promoted by Aβ
leading to Young’s modulus and cell height closer to the
control experiment, i.e., without the addition of Aβ and/or
dendrimer.
Our results confirm that the bioactivity of the dendrimers
directly relates to the number of Ga units. This was clear
comparing the results obtained for 2G0-GaOH and 2G1-
GaOH, where higher multivalency led to increased bioactivity.
The lower performance of 3G1-GaOH (the highest multi-
valency dendrimer analyzed) is explained by its higher
hydrophobic character that limits its solubility in water,
reducing the dendrimer−Aβ interactions. Importantly, the
increase of Ga units at the surface of the water-soluble
dendrimers increases the local concentration of Ga units in
their vicinity, making them more effective in modulating the
supramolecular aggregation of Aβ, as observed for 2G1-GaOH.
Importantly, in the presence of 2G1-GaOH, the kinetics of
assembly/disassembly of the oligomers seems to be affected,
and the formation of Aβ oligomers is no longer catalyzed by
the preexisting Aβ fibrils. Our results are consistent with the
inhibition of the self-replication of Aβ aggregates and of the
generation of toxic oligomers. Moreover, increased cellular
oxidative stress is usually considered a consequence of Aβ
toxicity.29 Importantly, polyphenols (e.g., tannic acid, TA)30
are known to reduce the concentration of reactive oxygen
species present in the (peri)cellular milieu. The proposed
dendrimers (e.g., 2G1-GaOH), by reducing the number of
cytotoxic aggregates, indirectly contribute to the maintenance
of the cellular oxidative stress within the healthy physiological
range. Finally, the higher hydrophobic character of the
dendrimers might be an advantage to cross the blood−brain
barrier when compared with natural polyphenols, such as TA,
that are known to present a low BBB permeability, to be
metabolized to lower-molecular-weight hydrolysable tannins
and readily metabolized by the body through sequential
enzymatic activity.31
4. CONCLUSIONS
We developed a strategy based on Ga-terminated dendrimers
to inhibit the primary and secondary nucleation of Aβ
fibrillization, as well as to disrupt the Aβ preformed fibrils.
As in the case of natural polyphenols, the activity of the
dendrimers was found to be proportional to the number of Ga
units. We also prove that the multivalent presentation of these
chemical motifs increases their capacity to remodel the Aβ
secondary structure. Since increasing the number of Ga units at
the surface of the dendrimer also increases its hydrophobic
character and reduces its solubility in water, 2G1-GaOH (6 Ga
units) emerges with a correct balance between solubility and
bioactivity. Indeed, 2G1-GaOH maximizes the interaction with
the Glu, Ala, and Asp amino acid residues (as shown by MD
simulations), while reducing the Aβ cytotoxicity in vitro. The
strategy herein presented can be extended to the development
of dendrimers with alternative structural cores and other
multivalent scaffolds aimed at abolishing the toxicity of Aβ
assemblies in the context of AD. Also, we believe that these
dendrimers represent relevant synthetic nanotools to study the
assembly mechanisms of different Aβ peptide sequences, as
well as to find structure−activity relationships of the Aβ
cytotoxic oligomeric populations that have been linked to AD.
Finally, our results set a strong background for testing the
ability of the proposed dendrimers to cross the blood−brain
barrier and reach the affected region of the brain, as well as to
evaluate them under an in vivo scenario.
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Hosť’álková, A.; Kucǎ, K.; Jun, D.; Opletal, L. Tannins and Their
Influence on Health. In Recent Advances in Medicinal Chemistry; ur
Rahman, A.; Choudhary, M. I.; Perry, G., Eds.; Elsevier, 2014; pp
159−208.
ACS Applied Materials & Interfaces www.acsami.org Research Article
https://doi.org/10.1021/acsami.1c17823
ACS Appl. Mater. Interfaces 2021, 13, 59673−59682
59682
